drugset
drugset / Trial / NCT05306379

Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin

NCT05306379 ↗

Phase 1 Completed 24 enrolled Aurinia Pharmaceuticals Inc.
NaSingle-groupOpen-labelOther

Summary

A single-center, open-label, Phase 1, drug-drug interaction study to investigate the effect of voclosporin on the pharmacokinetics of simvastatin and simvastatin acid in healthy volunteers.

Timeline

Start
2022-01-24
Primary completion
2022-04-05
Completion
2022-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg Oral
Subject Voclosporin Other / unclassified 23.7 mg Oral

Indications

No indication recorded.